H-L-beta-HLeu-OH*HCl

H-L-beta-HLeu-OH*HCl is a hydrochloride salt form of an L-configured β-homo leucine amino acid, featuring a chiral center at the α-carbon and a side chain extended by one methylene relative to leucine. The molecule presents a free carboxylic acid and a protonated amino functionality under salt conditions, enabling controlled peptide coupling after appropriate conversion to activated derivatives or temporary deprotection. The β-homo substitution changes steric and conformational preferences of the side chain, which can influence backbone-side-chain interactions in peptides and peptidomimetics. The HCl salt form improves handling and can support downstream transformations in protected amino acid synthesis workflows, while the amino acid functionality remains compatible with standard amide-forming chemistries.

1. Peptide Synthesis

H-L-beta-HLeu-OH*HCl supports peptide building block preparation where β-homo leucine incorporation is used to probe how side-chain length alters helix packing, hydrophobic contacts, and protease recognition patterns. The carboxylic acid and amino groups can be converted into coupling-ready forms, while the salt state can be managed through base treatment or in situ activation strategies to enable amide bond formation. Side-chain extension relative to leucine can be leveraged to construct analog series for peptide coupling chemistry, including C-terminal and internal residue placement. Resulting β-homo leucine-containing peptides serve as research-grade substrates for studying sequence-dependent folding and for generating peptidomimetic scaffolds with altered conformational behavior.

2. Unnatural Amino Acid Incorporation

H-L-beta-HLeu-OH*HCl functions as a chiral amino acid intermediate for unnatural amino acid incorporation strategies that require stereodefined β-amino acid side-chain topology. The L-configuration at the α-carbon provides stereochemical control for downstream derivative formation, while the extended aliphatic side chain can be used to tune hydrophobicity and steric bulk in molecular design. Salt-stabilized amino acid handling can facilitate conversion into orthogonally protected derivatives, enabling selective N-protection and carboxyl activation for stepwise assembly. β-homo leucine analogs prepared from this intermediate can be applied to structure-activity relationship studies, combinatorial peptide libraries, and SAR-focused scaffold diversification.

3. Side-Chain Functionalization

H-L-beta-HLeu-OH*HCl can be employed in side-chain functionalization workflows where the extended aliphatic chain provides a platform for further chemical modification beyond canonical leucine chemistry. The amino acid core enables derivatization at the N-terminus and carboxyl terminus through protection-group strategies, allowing selective transformations that preserve the stereocenter during functional group installation. The β-homo leucine framework can be converted into functionalized residues such as alkyl-modified or reactive side-chain analogs, supporting conjugation handles for downstream biomolecule labeling. Functionalized derivatives derived from this amino acid can be used to generate peptide conjugates, affinity probes, and chemical biology reagents that rely on controlled hydrophobic spacing and stereodefined attachment points.

4. Protected Amino Acid Chemistry

H-L-beta-HLeu-OH*HCl is suitable for protected amino acid synthesis routes that require reliable conversion from a salt form into coupling-compatible protected derivatives. The presence of a free carboxylic acid and amino functionality enables standard protection-group strategies, such as N-protection for selective peptide coupling and carboxyl activation for amide formation while maintaining the L stereochemistry. The β-homo leucine side chain can tolerate typical protection and deprotection sequences used in peptide building block preparation, supporting iterative assembly in solid-phase or solution-phase contexts. Downstream protected derivatives prepared from this starting material can serve as intermediates for fine chemical synthesis and for manufacturing of peptide reagents used in research and industrial peptide production.

5. Process Chemistry Intermediate

H-L-beta-HLeu-OH*HCl can be applied as a chiral amino acid intermediate in process chemistry for producing β-homo leucine-containing peptide fragments and related intermediates at scale. The hydrochloride salt form provides a practical handle for consistent feedstock preparation, while the defined stereochemistry supports reproducible downstream conversion to activated esters, coupling reagents, or protected building blocks. Carboxyl functionality and the amino group enable integration into manufacturing routes that rely on controlled activation and protection/deprotection cycles, including preparation of residue forms compatible with peptide coupling chemistry. Industrially, this intermediate can support specialty chemical production where β-homo leucine residues are required for generating conformationally tuned peptide analogs, peptidomimetics, and process intermediates used in applied peptide science.

6. Analytical Research Standards

H-L-beta-HLeu-OH*HCl can serve as an analytical reference material for amino acid and peptide characterization workflows, particularly when β-homo leucine-containing species are monitored. The defined L stereochemistry and distinct β-homo side-chain length can help differentiate it from isomeric or structurally related amino acids during chromatographic and mass spectrometric analyses. Salt-state behavior and the free carboxylic acid and amino groups support preparation of derivatization standards for method development in amino acid profiling, peptide hydrolysate analysis, and impurity tracking. Analytical standards generated from this compound can support quality control of peptide building block preparation and enable reliable identification of β-homo leucine residues in research-grade peptide materials.

1. Therapeutic potential of an intestinotrophic hormone, glucagon-like peptide 2, for treatment of type 2 short bowel syndrome rats with intestinal bacterial and fungal dysbiosis

2. A possible role of tachykinin-related peptide on an immune system activity of mealworm beetle, Tenebrio molitor L

3. Cationic cell-penetrating peptides are potent furin inhibitors

4. Constitutive and inflammation-dependent antimicrobial peptides produced by epithelium are differentially processed and inactivated by the commensal Finegoldia magna and the pathogen Streptococcus pyogenes

5. Myotropic activity of allatostatins in tenebrionid beetles